Last Updated：2025/12/05
In the clinical trial, patients treated with vosaroxin experienced a notable decrease in leukemic blast counts.
See correct answer
In the clinical trial, patients treated with vosaroxin experienced a notable decrease in leukemic blast counts.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
